| Ident. | Authors (with country if any) | Title |
|---|
| 000056 |
Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Non-human primate models of PD to test novel therapies. |
| 000065 |
Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research. |
| 000094 |
Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Effects of progesterone administered after MPTP on dopaminergic neurons of male mice. |
| 000167 |
Sarah Petryszyn [Canada] ; Thérèse Di Paolo [Canada] ; André Parent [Canada] ; Martin Parent [Canada] | The number of striatal cholinergic interneurons expressing calretinin is increased in parkinsonian monkeys. |
| 000243 |
Edith Miville-Godbout [Canada] ; Mélanie Bourque [Canada] ; Marc Morissette [Canada] ; Sara Al-Sweidi [Canada] ; Tara Smith [Canada] ; Asuka Mochizuki [Canada, Japon] ; Vijitha Senanayake [Canada] ; Dushmanthi Jayasinghe [Canada] ; Li Wang [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada] | Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice |
| 000274 |
Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease. |
| 000345 |
Andrée-Anne Poirier [Canada] ; Benoit Aubé [Canada] ; Mélissa Côté [Canada] ; Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada] ; Denis Soulet [Canada] | Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments |
| 000424 |
Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients. |
| 000456 |
Claudia Trenkwalder [Allemagne] ; Daniela Berg [Allemagne] ; Olivier Rascol [France] ; Karla Eggert [Allemagne] ; Andres Ceballos-Baumann [Allemagne] ; Jean-Christophe Corvol [France] ; Alexander Storch [Allemagne] ; Lin Zhang [États-Unis] ; Jean-Philippe Azulay [France] ; Emmanuel Broussolle [France] ; Luc Defebvre [France] ; Christian Geny [France] ; Michal Gostkowski [États-Unis] ; Fabrizio Stocchi [Italie] ; Christine Tranchant [France] ; Pascal Derkinderen [France] ; Franck Durif [France] ; Alberto J. Espay [États-Unis] ; Andrew Feigin [États-Unis] ; Jean-Luc Houeto [France] ; Johannes Schwarz [Allemagne] ; Thérèse Di Paolo [Canada] ; Dominik Feuerbach [Suisse] ; Hans-Ulrich Hockey [Suisse] ; Judith Jaeger [États-Unis] ; Annamaria Jakab [Suisse] ; Donald Johns [États-Unis] ; Gurutz Linazasoro [Espagne] ; Paul Maruff [États-Unis] ; Izabela Rozenberg [Suisse] ; Judit Sovago [Suisse] ; Markus Weiss [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia. |
| 000580 |
Laurent Grégoire [Canada] ; Tara Smith [Canada] ; Vijitha Senanayake [Canada] ; Asuka Mochizuki [Japon] ; Edith Miville-Godbout [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada] | Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys. |
| 000786 |
Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications. |
| 000871 |
Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada] | Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. |
| 000920 |
Vincent A. Jourdain [Canada] ; Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Thérèse Di Paolo [Canada] | Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys. |
| 000973 |
Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada] | Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates |
| 000999 |
Nicolas Morin [Canada] ; Vincent A. Jourdain [Canada] ; Thérèse Di Paolo [Canada] | Modeling dyskinesia in animal models of Parkinson disease. |
| 000A29 |
Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada] | Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease. |
| 000B60 |
Thérèse Di Paolo [Canada] ; Laurent Grégoire [Canada] ; Dominik Feuerbach [Canada] ; Walid Elbast [Canada] ; Markus Weiss [Canada] ; Baltazar Gomez-Mancilla [Canada] | AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys. |
| 000B94 |
Nicolas Morin [Canada] ; Vincent A. Jourdain ; Thérèse Di Paolo | Modeling dyskinesia in animal models of Parkinson disease : ANIMAL MODELS OF PARKINSON'S DISEASE |
| 000C92 |
Vincent A. Jourdain [Canada] ; Laurent Grégoire ; Marc Morissette ; Nicolas Morin ; Martin Parent ; Thérèse Di Paolo | Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy. |
| 000D33 |
Fabrizio Gasparini [Suisse] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Suisse] | Metabotropic Glutamate Receptors for Parkinson's Disease Therapy |
| 000D42 |
Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo | MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates. |
| 000D83 |
Maria Gabriela Sánchez [Canada] ; Marc Morissette ; Thérèse Di Paolo | Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys. |
| 000E29 |
Nicolas Morin [Canada] ; Marc Morissette ; Laurent Grégoire ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo | Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys. |
| 001072 |
Maria Gabriela Sanchez [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys |
| 001130 |
Mélanie Bourque [Canada] ; Dean E. Dluzen ; Thérèse Di Paolo | Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease. |
| 001255 |
Sarah Paris-Robidas [Canada] ; Elodie Brochu ; Marion Sintes ; Vincent Emond ; Mélanie Bousquet ; Milène Vandal ; Mireille Pilote ; Cyntia Tremblay ; Thérèse Di Paolo ; Ali H. Rajput ; Alex Rajput ; Frédéric Calon | Defective dentate nucleus GABA receptors in essential tremor. |
| 001534 |
Golnasim Riahi [Canada] ; Marc Morissette [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Pershia Samadi [Canada] ; Martin Parent [Canada] ; Thérèse Di Paolo [Canada] | Effect of chronic L-DOPA treatment on 5-HT1A receptors in parkinsonian monkey brain |
| 001639 |
Mélanie Bourque [Canada] ; Dean E. Dluzen [États-Unis] ; Thérèse Di Paolo [Canada] | Male/Female Differences in Neuroprotection and Neuromodulation of Brain Dopamine |
| 001676 |
Maria Gabriela Sánchez [Canada] ; Erika Estrada-Camarena ; Nancy Bélanger ; Marc Morissette ; Thérèse Di Paolo | Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy. |
| 001893 |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
| 001A57 |
Bazoumana Ouattara [Canada] ; Fabrizio Gasparini ; Marc Morissette ; Laurent Grégoire ; Pershia Samadi ; Baltazar Gomez-Mancilla ; Thérèse Di Paolo | Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. |
| 001C61 |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Daniel Lévesque [Canada] ; Thérèse Di Paolo [Canada] | BDNF levels are not related with levodopa‐induced dyskinesias in MPTP monkeys |
| 001C80 |
Marc Morissette [Canada] ; Pershia Samadi [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Nancy Belanger [Canada] ; Thérèse Di Paolo [Canada] | Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys |
| 001D20 |
Bazoumana Ouattara [Canada] ; Fabrizio Gasparini [Suisse] ; Marc Morissette [Canada] ; Laurent Gregoire [Canada] ; Pershia Samadi [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Thérèse Di Paolo [Canada] | Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys |
| 001E06 |
Mélanie Bourque [Canada] ; Dean E. Dluzen ; Thérèse Di Paolo | Neuroprotective actions of sex steroids in Parkinson's disease. |
| 002016 |
Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys |
| 002100 |
JING JI [États-Unis] ; Mélanie Bourque [Canada] ; Thérèse Di Paolo [Canada] ; Dean E. Dluzen [États-Unis] | Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems |
| 002196 |
Marc Morissette [Canada] ; Sara Al Sweidi ; Sophie Callier ; Thérèse Di Paolo | Estrogen and SERM neuroprotection in animal models of Parkinson's disease. |
| 002296 |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys |
| 002799 |
Maryvonne Le Saux [Canada] ; Erika Estrada-Camarena [Canada] ; Thérèse Di Paolo [Canada] | Selective estrogen receptor‐α but not ‐β agonist treatment modulates brain α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors |
| 002805 |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin |
| 002806 |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors |
| 002851 |
Pershia Samadi [Canada] ; Laurent Grégoire [Canada] ; Claude Rouillard [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] ; Daniel Lévesque [Canada] | Docosahexaenoic acid reduces levodopa‐induced dyskinesias in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine monkeys |
| 002914 |
Carl Julien [Canada] ; Line Berthiaume [Canada] ; Abdallah Hadj-Tahar [Canada] ; Ali H. Rajput [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] ; Pierre Julien [Canada] ; Frédéric Calon [Canada] | Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys |
| 002A34 |
Myreille D'Astous [Canada] ; Marc Morissette [Canada] ; Sophie Callier [Canada] ; Thérèse Di Paolo [Canada] | Regulation of striatal preproenkephalin mRNA levels in MPTP‐lesioned mice treated with estradiol |
| 002D75 |
Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di Paolo | Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. |
| 002D83 |
Nancy Bélanger [Canada] ; Laurent Grégoire ; Paul Bédard ; Thérèse Di Paolo | Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. |
| 002E75 |
Myreille D'Astous [Canada] ; Marc Morissette [Canada] ; Bastien Tanguay [Canada] ; Sophie Callier [Canada] ; Thérèse Di Paolo [Canada] | Dehydroepiandrosterone (DHEA) such as 17β‐estradiol prevents MPTP‐induced dopamine depletion in mice |
| 002F48 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications |
| 003076 |
Frédéric Calon [Canada] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias |
| 003084 |
Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France] | Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture |
| 003085 |
Michel Cyr [Canada] ; Frederic Calon [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease |
| 003103 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment |
| 003195 |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grandbois [Canada] ; Didier Pélaprat [France] ; Thérèse Di Paolo [Canada] | Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice |
| 003237 |
Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter |
| 003289 |
Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Daniel Levesque [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model |
| 003440 |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
| 003512 |
Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Pierre J. Blanchet [Canada] ; Marc Morissette [Canada] ; Richard Grondin [Canada] ; Martin Goulet [Canada] ; Jean-Pierre Doucet [Canada] ; George S. Robertson [Canada] ; Eric Nestler [États-Unis] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada] | Dopamine-receptor stimulation: biobehavioral and biochemical consequences |
| 003672 |
Richard Grondin [Canada] ; Martin Goulet [Canada] ; Marc Morissette [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958 |
| 003681 |
Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo [Canada] | Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content |
| 003A98 |
Marc Morissette [Canada] ; Martin Goulet [Canada] ; Jean-Jacques Soghomonian [Canada] ; Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy |
| 003D21 |
Jean-Jacques Soghomonian [Canada] ; Sophie Pedneault [Canada] ; Pierre J. Blanchet [Canada] ; Martin Goulet [Canada] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada] | l-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys |
| 003F76 |
Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors |
| 004899 |
Céline Gagnon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists |
| 004B76 |
Claude Rouillard [Canada] ; Paul Bédard [Canada] ; Pierre Falardeau [Canada] ; Thérèse Di Paolo [Canada] | Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion |
